Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Observational
SUMMARY
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:
• Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
• With National Health Assurance
• Able to consent to the study
Locations
Other Locations
France
Purpan University Hospital
RECRUITING
Toulouse
Contact Information
Primary
Adeline RUYSSEN-WITRAND, MD
ruyssen-witrand.a@chu-toulouse.fr
561775626
Backup
Delphine THUILLEZ
thuillez.d@chu-toulouse.fr
561776966
Time Frame
Start Date: 2021-09-13
Estimated Completion Date: 2031-09-01
Participants
Target number of participants: 2000
Treatments
patients initiating a biotherapy or a target treatment
Blood sampling
patients with chronic inflammatory rheumatism, weakening osteopathy or mechanical pathology
Blood sampling
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Toulouse